Skip to main content
. 2016 Apr 18;52(2):697–719. doi: 10.1111/1475-6773.12492

Table 2.

Use and Cost of Prescription Drugs, Physician Services, and Hospital Services per Person in Prescription Drug User Groups, 2011 or Most Recent High‐Cost Year

Persistent Nonusers Persistent Low‐Cost Users Persistent Average‐Cost User Persistent Moderate‐Cost User Sporadic Low‐to‐High‐Cost Users Transition to HCU Transition from HCU (2011) Transition from HCU (High‐cost year) Episodic‐HCU (2011) Episodic‐HCU (High‐cost year) Persistent‐HCU
Prescription drugs
Average total cost $0 $12 $131 $1,587 $663 $3,266 $267 $2,663 $255 $3,485 $4,192
Median total cost $0 $0 $78 $1,231 $612 $2,020 $264 $1,857 $235 $1,958 $2,960
Interquartile range of total costs ($0, $0) ($0, $22) ($12, $205) ($942, $1,693) ($337, $857) ($1,622, $2,925) ($27, $471) ($1,579, $2,533) ($57, $438) ($1,624, $3,090) ($2,112, $4,533)
Average prescriptions filled 0.0 0.6 3.7 33.7 14.3 55.0 13.0 46.7 8.5 32.5 92.4
Percentage for chronic conditions 38.7 69.0 92.3 86.2 93.6 90.2 92.1 83.6 87.3 95.2
Average days of drug supplied 0.0 8.1 133.1 1,317.1 589.2 1,251.8 376.3 1,203.5 290.1 750.0 2,276.2
Percentage for chronic conditions 56.9 88.2 96.2 94.0 94.9 94.6 94.4 92.7 90.9 96.4
Average number of drug groups 0.0 0.5 2.0 6.8 4.4 7.2 3.2 6.9 3.1 6.5 9.8
Physician services
Average total cost $87 $172 $452 $1,386 $956a $1,900 $909b $2,094 $930a,b $2,094 $1,999
Median total cost $0 $59 $230 $911 $578 $1,233 $472 $998 $536 $1,397 $1,389
Interquartile range of total costs ($0, $33) ($0, $189) ($73, $532) ($478, $1,693) ($274, $1,149) ($644, $2,333) ($150, $1,059) ($493, $1,999) ($212, $1,108) ($694, $2,677) ($764, $2,459)
Average number of providers 0.9 2.1 4.4 8.9 7.1 10.9 6.1 10.0 6.8 12.2 11.4
Average number of visits 1.5 3.1 7.7 21.7 15.2 28.5 14.6c 25.5 14.1c 29.6 31.2
Percentage of visits to specialists 39 38 41 48 46 51 43 47 49 58 50
Hospital services
Average total cost $112d $97d $333 $1,915 $1,130 $3,525 $2,489 $3,230e $1,404 $4,151 $3,264e
Median total cost $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Interquartile range of total costs ($0, $0) ($0, $0) ($0, $0) ($0, $328) ($0, $0) ($0, $1,274) ($0, $0) ($0, $636) ($0, $0) ($0, $3,374) ($0, $959)
Rate of hospitalization 2 4 10 25 19 33 19 29 20 39 33
Hospitalizations per user 1.3f 1.1 1.2 1.5 1.4g 1.7j 1.4h 1.6I,j 1.3f,g,h 1.8 1.7i
Percentage of urgent visits 45 23 21 35 29 47 51 48 33 43 45
Length of stay per visit 5.9 2.0 2.4 4.9 4.0 6.0 10.5 7.5 5.2 5.3 5.9
Percentage of day visits 48 68 64 57 60 45 42 59 53 59 49

All pairwise differences in measures of average use and cost are statistically significant at p = .001, except as noted with superscript references; for example, a = difference between episodic‐HCUs (in high‐cost year) and persistent moderate‐cost users not significant at p = .001. Costs for episodic‐HCUs and transitions from HCU during their most recent high‐cost year are adjusted for inflation. Drug groups measured using the WHO ATC system, third level, therapeutic/pharmacological subgroup.